| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3002861 | Nutrition, Metabolism and Cardiovascular Diseases | 2007 | 6 Pages |
Abstract
The 6-month treatment with orlistat had a beneficial effect on the lipid profile and improved the antioxidant status by increasing serum PON1 activity. However, because of the limited therapeutic effectiveness, obese patients with hypercholesterolemia should receive additional lipid lowering medications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mária Audikovszky, Gyula Pados, Ildikó Seres, Mariann Harangi, Péter Fülöp, Evelin Katona, László Illyés, Gábor Winkler, Ãva M. Katona, György Paragh,